MedStar Authors catalog › Details for: A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds. [Review]
Normal view MARC view ISBD view

A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds. [Review]

by Waksman, Ron.
Citation: Cleveland Clinic Journal of Medicine. 84(12 Suppl 4):e20-e24, 2017 Dec.Journal: Cleveland Clinic journal of medicine.Published: ; 2017ISSN: 0891-1150.Full author list: Waksman R.UI/PMID: 29281608.Subject(s): *Absorbable Implants | *Coronary Artery Disease/su [Surgery] | Coronary Restenosis/et [Etiology] | *Coronary Restenosis/pc [Prevention & Control] | Drug-Eluting Stents/ae [Adverse Effects] | Drug-Eluting Stents/cl [Classification] | *Drug-Eluting Stents | Humans | Percutaneous Coronary Intervention/ae [Adverse Effects] | Percutaneous Coronary Intervention/is [Instrumentation] | Percutaneous Coronary Intervention/mt [Methods] | *Percutaneous Coronary Intervention | *Tissue Scaffolds | Treatment OutcomeInstitution(s): MedStar Heart & Vascular InstituteonActivity type: Journal Article.Medline article type(s): Journal Article | ReviewOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.3949/ccjm.84.s4.05 (Click here) Abbreviated citation: Cleve Clin J Med. 84(12 Suppl 4):e20-e24, 2017 Dec.Local Holdings: Available online through MWHC library: 2001- 2010, Available in print through MWHC library: 2002 - present.Abstract: Drug-eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES had durable polymers that provided acceptable efficacy outcomes but had high rates of stent thrombosis leading to myocardial infarction and death. Second-generation DES have improved outcomes by reducing stent thrombosis and recurrent stenosis. Newer DES with biodegradable polymers have similar efficacy as second-generation DES, but have higher rates of stent thrombosis. This review compares outcomes of bioresorbable scaffolds and looks at stent technology developments that may improve outcomes. Copyright (c) 2017 Cleveland Clinic.

Powered by Koha